This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Yao Yang in Pharmaceutical Chemistry
Introduction
Yao Yang is an accomplished inventor based in Changsu, China, recognized for his contributions to the field of pharmaceutical chemistry. With a keen focus on the development of NEP inhibitors, Yao has made significant strides in the production of key intermediates essential for the manufacture of advanced drug formulations.
Latest Patents
Yao Yang holds a patent titled "Process for Early Sacubitril Intermediates." This invention pertains to a new enantioselective process designed for producing valuable intermediates that are critical for the development of NEP inhibitors or their prodrugs. The process specifically highlights a focus on compounds that include a γ-amino-δ-biphenyl-α-methylalkanoic acid or acid ester backbone, showcasing Yao's innovative approach to enhancing pharmaceutical manufacturing.
Career Highlights
Currently, Yao Yang is affiliated with Novartis AG, a leading global healthcare company renowned for its commitment to innovation and excellence in the pharmaceutical sector. His role at Novartis has allowed him to apply his inventive ideas to real-world challenges in medicine, driving advancements in drug development.
Collaborations
Throughout his career, Yao has collaborated with notable coworkers, including Florian Karl Kleinbeck-Riniker and Tobias Kapferer. These partnerships enhance the creative environment necessary for innovative research and development, fostering a culture of collaboration that is essential in the field of pharmaceutical sciences.
Conclusion
Yao Yang stands out as a prominent inventor in the pharmaceutical industry, particularly with his patent contributions that advance the production of essential drug intermediates. His career at Novartis AG and collaboration with talented colleagues reflect his dedication to innovation and the pursuit of excellence in pharmaceutical chemistry. As the industry evolves, Yao's work continues to be a vital part of shaping the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile